Abstract The Washington University School of Medicine Knight Alzheimer Disease Research
Center's “African American Participation in Alzheimer Disease Research: Effective …

African Americans experience a greater risk of Alzheimer disease (AD), but are
underrepresented in AD research. Our study examined barriers and facilitators of AD …

Personalized medicine aims to tailor diagnosis and treatment based on an individual's
personal genetic make-up and other predictive biomarkers—rather than a one-size fits all …

African Americans experience higher incidence and prevalence of Alzheimer's disease
(AD). Yet, they continue to be underrepresented in AD research, limiting the ability to …

Background: United States Census Bureau projects African Americans (AAs) will be one of
the fastest growing populations over the next 30 years. Research suggests they are at …

Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD)
disproportionally affect Hispanic and Latino populations, yet Hispanics/Latinos are …

Abstract The Alzheimer's Association and National Institutes of Health have emphasized the
need for participation of racial/ethnic populations in Alzheimer disease (AD) clinical …

African American participation in Alzheimer's disease (AD) research studies has been
historically low. To determine whether older African Americans and Caucasians had …

Despite the need for minority subjects in research studies of Alzheimer disease (AD), the
successful involvement of minority patients in such studies has been difficult. This report …

The poor generalizability of clinical research data due to the enrollment of highly educated,
non‐Latinx White participants hampers the development of therapies for Alzheimer's …